
WellPoint is owned by Elevance Health, Inc. (NYSE: ELV), a publicly traded American health benefits company headquartered in Indianapolis, Indiana. Elevance Health relaunched the WellPoint brand in January 2024 by rebranding its Amerigroup health plans in six states (Arizona, Iowa, New Jersey, Tennessee, Texas, and Washington) to WellPoint. The WellPoint brand serves Medicaid, CHIP, and Medicare members in states where Elevance Health does not offer Blue Cross Blue Shield branded products. Elevance Health serves approximately 112 million consumers through its affiliated companies.
Parent Company
Founded
2024
Status
Publicly Traded
Headquarters
| Brand | Parent Company | Ownership Type |
|---|---|---|
| WellPoint | Elevance Health Inc. | Wholly owned |
The WellPoint name has a long history within the health insurance industry, predating its current use as Elevance Health's Medicaid brand by several decades.
The original WellPoint Health Networks was established in 1992 as the for-profit subsidiary of Blue Cross of California. WellPoint Health Networks went public in 1993, becoming one of the first Blue Cross Blue Shield affiliated companies to trade on a public stock exchange. The company grew through acquisitions of other Blue Cross Blue Shield plans, including Blue Cross and Blue Shield of Georgia in 1996 and Blue Cross and Blue Shield of Missouri in 2001.
In 2004, WellPoint Health Networks merged with Anthem, Inc. in a transaction valued at approximately $16.4 billion. The combined company took the WellPoint name, becoming WellPoint, Inc., the largest health insurer in the United States by enrollment at the time.
WellPoint, Inc. continued to grow through acquisitions, including the acquisition of Amerigroup Corporation in 2012 for approximately $4.9 billion. Amerigroup was a managed care company specializing in Medicaid and government-sponsored health programs.
In 2014, WellPoint, Inc. reverted to the Anthem name, reflecting the company's Blue Cross Blue Shield heritage. The WellPoint name was retired as a corporate brand.
In June 2022, Anthem announced its corporate rebrand to Elevance Health, Inc. Simultaneously, the company announced that it would relaunch the WellPoint brand for its government health plan operations in states where Elevance Health does not offer Blue Cross Blue Shield branded products.
The WellPoint rebrand took effect in January 2024, when Elevance Health's Amerigroup health plans in six states (Arizona, Iowa, New Jersey, Tennessee, Texas, and Washington) were rebranded as WellPoint. The rebrand affected Medicaid, CHIP, and Medicare members in those states, who received new WellPoint-branded insurance cards and communications.
In 2025 and 2026, Elevance Health faced pressure on Medicaid margins due to state contract repricing and eligibility redeterminations following the end of the COVID-19 public health emergency. The company has focused on improving operational efficiency and growing its government business segment, which includes the WellPoint brand.
What does Elevance Health own?
Elevance Health owns Anthem Blue Cross Blue Shield health insurance plans operating in 14 states, the Wellpoint subsidiary brand, and the Carelon health services brand including CarelonRx (pharmacy benefits management) and Carelon Services (behavioural health, care management, and risk-based solutions). The company also offers dental insurance through Anthem Dental Plans and Blue Cross Blue Shield Dental. Elevance was formerly known as Anthem until rebranding in June 2022.
Is Elevance Health publicly traded?
Yes. Elevance Health is listed on the New York Stock Exchange under the ticker symbol ELV. The company has been publicly traded since 2004, when it IPO'd under the name Anthem with ticker ANTM. The ticker changed to ELV in June 2022 when the company rebranded to Elevance Health. Major institutional shareholders include Vanguard Group, BlackRock, and State Street Corporation. The company returned $4.1 billion of capital to shareholders in 2025.
Who founded Elevance Health?
Elevance Health was formed through decades of mergers among Blue Cross and Blue Shield organisations, beginning in 1946. The current corporate structure resulted from the 2004 merger of Anthem and WellPoint Health Networks, which brought multiple state Blue Cross Blue Shield plans under a single entity. The company adopted the Anthem name in 2004 and rebranded to Elevance Health in June 2022 under CEO Gail Boudreaux's leadership.
Where is Elevance Health headquartered?
Elevance Health is headquartered in Indianapolis, Indiana, USA. The company operates Blue Cross Blue Shield plans in 14 states and serves approximately 45 million medical members across the United States. The company employs approximately 100,000 people. Carelon, the company's health services subsidiary, operates pharmacy benefits management, behavioural health, and care management services.
What is Elevance Health's annual revenue?
Elevance reported $197.6 billion in operating revenue for FY2025, a 12.8% increase from $175.2 billion in FY2024. Premium revenue was $164.6 billion, product revenue was $24.5 billion, and service fees were $8.5 billion. Shareholders' net income was $5.66 billion, with GAAP diluted EPS of $25.21. For FY2026, the company projects total operating revenue to decline in the low single digits, with GAAP diluted EPS of at least $22.30 and adjusted diluted EPS of at least $25.50.
Why is Elevance Health exiting Medicaid markets?
Elevance is exiting Medicaid markets where it cannot achieve sustainable margins due to elevated medical cost trends and state rate updates that have not kept pace with the higher acuity of remaining members after pandemic-era redetermination. The company exited the Washington, D.C. Medicaid market in August 2025 and expects to exit additional markets over 12 to 18 months. Medicaid is expected to operate at a -1.75% operating margin in 2026. CEO Gail Boudreaux stated that "Medicaid participation has to make strategic and financial sense for us within our diversified portfolio."
What is the DOJ lawsuit against Elevance Health about?
In May 2025, the US Department of Justice filed a False Claims Act complaint against Elevance Health, CVS Health (Aetna), and Humana, alleging the insurers paid hundreds of millions of dollars in illegal kickbacks to insurance brokers eHealth, GoHealth, and SelectQuote from 2016 through at least 2021 in exchange for Medicare Advantage enrolments. The DOJ alleges brokers directed beneficiaries to plans that paid the most in kickbacks regardless of suitability. The case is ongoing, and the claims are allegations only with no determination of liability.
WellPoint operates under Elevance Health's corporate sustainability framework, focusing on healthcare access, community health programs, and health equity initiatives.
WellPoint maintains programs to improve healthcare access for underserved populations, including Medicaid beneficiaries with complex health needs and limited resources. The company's health equity initiatives focus on reducing healthcare disparities through culturally competent care, language access services, and targeted outreach to vulnerable populations.
WellPoint invests in community-based health initiatives that address social determinants of health, including nutrition assistance, transportation services, and housing support for Medicaid and Medicare beneficiaries. The company partners with local organizations to improve health outcomes and reduce healthcare costs through preventive care.
WellPoint leverages Elevance Health's digital health capabilities to improve access to care, particularly for members with mobility limitations or those in rural areas. The company's digital platforms enable virtual care visits, remote monitoring, and digital medication management.
WellPoint maintains comprehensive ethical governance standards and compliance programs to ensure proper stewardship of public healthcare funds. The company's compliance programs are designed to prevent improper billing practices and ensure appropriate use of taxpayer-funded healthcare resources.
WellPoint has achieved strong quality ratings from state Medicaid agencies and the National Committee for Quality Assurance (NCQA) for its Medicaid managed care operations. These ratings measure plan performance on quality, access, and customer satisfaction.
WellPoint has received awards for its community health programs and partnerships with organizations serving elderly, disabled, and low-income populations. The company's preventive care initiatives and health education programs have been recognized by state health departments.
WellPoint's programs addressing health disparities and social determinants of health have received recognition from healthcare advocacy organizations and public health associations.
WellPoint's telehealth and digital health initiatives have received recognition from healthcare technology organizations for improving access to care for Medicaid and Medicare beneficiaries.
Brand Transition Challenges (2024): The January 2024 relaunch from the Amerigroup brand required significant member communication and operational changes. The transition created potential confusion among members and providers, requiring extensive outreach to ensure continuity of care and proper understanding of the new brand identity.
Medicaid Contract Competition: WellPoint operates in highly competitive Medicaid managed care markets where state governments periodically issue requests for proposals and award multi-year contracts. The competitive bidding process creates revenue uncertainty and requires continuous investment in proposal development and cost management.
Medicaid Margin Pressure: WellPoint faces ongoing pressure on Medicaid margins from state contract repricing and increasing medical cost trends. These financial pressures require continuous adaptation of benefit design, cost management strategies, and operational efficiency improvements.
Regulatory Compliance: As a government-sponsored health plan provider, WellPoint faces ongoing regulatory scrutiny from state Medicaid agencies, CMS, and other healthcare regulators. These requirements include complex reporting obligations, quality measurement programs, and compliance audits.
Provider Network Disputes: WellPoint has faced occasional disputes with healthcare providers over reimbursement rates and network participation agreements. These disputes have sometimes resulted in temporary disruptions in provider access for members.
Geographic Concentration Risk: WellPoint's operations are concentrated in six states, creating geographic concentration risk. The brand's performance is dependent on the Medicaid program policies and contract decisions of a small number of state governments.
Data Privacy and Security: WellPoint handles sensitive member health information and faces ongoing challenges related to data privacy, cybersecurity, and compliance with healthcare privacy regulations including HIPAA.
These competing brands operate in the same categories and provide similar products or services. Compare key attributes to understand market positioning and competitive landscape.
| Brand | Parent Company | Country | Founded | Market Position | Primary Market | Gender Target |
|---|---|---|---|---|---|---|
| Centene | USA | 1985 | Mass market | United states | All-ages | |
| Cvs Health | United States | 1853 | Mass market | North america | All Genders | |
| Cigna | USA | 1982 | Mass market | United states | All Genders |
Healthcare PharmaceuticalsOwned by Centene Corporation
Centene Corporation's national Medicare Advantage and prescription drug plan brand, acquired from WellCare Health Plans for $17.3 billion in January 2020.
Healthcare PharmaceuticalsOwned by CVS Health Corporation
American managed care and health insurance company offering medical, dental, pharmacy, and behavioral health plans, operating as a subsidiary of CVS Health Corporation.
Healthcare PharmaceuticalsOwned by The Cigna Group
American health insurance brand providing medical coverage, health plans, and wellness services for individuals, families, and employers through The Cigna Group.
Market Positioning: WellPoint competes with 3 brands in the same categories, ranging from mass market to luxury positioning.
Geographic Distribution: Competitors are headquartered across multiple regions, indicating global competition in this market segment.
Brand Heritage: Competitor brands range from established heritage brands to newer market entrants, with founding years spanning several decades.
Looking for brands with different ownership structures? These similar brands are not owned by Elevance Health Inc., giving you alternative choices that support different corporate structures.
Healthcare PharmaceuticalsOwned by Herbalife Ltd.
Global nutrition and weight-management brand owned by Herbalife Ltd. and sold through independent distributors in more than 90 markets.
Herbalife operates independently without a large parent corporation.
Healthcare PharmaceuticalsOwned by Chempro Chemists
Australian online pharmacy operated by Chempro Chemists from Molendinar, Queensland. Offers prescription medications, health products, and wellness items through digital platforms and mail-order delivery.
Pharmacy Direct is privately owned, unlike WellPoint which is under a publicly traded parent company.
Healthcare PharmaceuticalsOwned by GE HealthCare Technologies Inc.
Independent publicly traded healthcare technology company spun off from General Electric in January 2023, providing medical imaging, diagnostics, and healthcare IT solutions globally.
GE HealthCare operates independently without a large parent corporation.
Healthcare PharmaceuticalsOwned by GoodRx Holdings, Inc.
American healthcare technology platform providing prescription drug price comparison, discount coupons, and telehealth services to help consumers find affordable healthcare options.
GoodRx operates independently without a large parent corporation.
Healthcare PharmaceuticalsOwned by Alcon Inc.
Independent publicly traded global eye care company headquartered in Geneva, Switzerland, specializing in surgical equipment, contact lenses, and ophthalmic products. Spun off from Novartis in April 2019.
Alcon operates independently without a large parent corporation.
Owned by Menicon Co., Ltd.
Japan's first and largest contact lens manufacturer, founded in 1951 in Nagoya. Known for rigid gas permeable lenses, orthokeratology, and expanding daily disposable silicone hydrogel products.
Menicon operates independently without a large parent corporation.
Discover popular brands and companies in the Healthcare & Pharmaceuticals category and related searches from other users.

Abbokinase (urokinase) is a thrombolytic medication historically used for pulmonary embolism and catheter clearance. Originally marketed by Abbott Laboratories, now owned by Microbix Biosystems as Kinlytic. FDA-approved since 1978.

Prescription isotretinoin brand developed by Roche and approved by the FDA in 1982 for severe nodular acne. Roche discontinued the brand name in the United States in 2009; the drug continues as Roaccutane in international markets.

Activase (alteplase) is a prescription thrombolytic medication manufactured by Genentech, a wholly-owned subsidiary of Roche. Used to treat acute ischemic stroke, heart attack, and pulmonary embolism.